Major pharmaceutical wholesaler Medipal Holdings changed its top management for the first time in 14 years, with Imagawa Kuniaki (今川国明) appointed as the new president. Former president Watanabe Shuichi (渡辺秀一) moved to the position of chairman. The change has been reported to have followed a dispute with a UK investment fund.
Medipal Holdings, a major pharmaceutical wholesaler, changed its top management for the first time in 14 years, with Imagawa Kuniaki (今川国明) appointed as president. Former president Watanabe Shuichi (渡辺秀一) moved to the position of chairman.
A dispute with a UK investment fund has been reported as a factor behind the new management structure, with improvements in capital efficiency and business reform being sought.
The article points out that pressure from UK funds is spreading to other companies in the industry, driving increased activity around the maximization of shareholder value.
Improving capital efficiency and organizational reform across the pharmaceutical wholesaling industry have been identified as challenges going forward.